Despite a press release from Dendreon Corporation (Nasdaq: DNDN) this morning announcing that PROVENGE significantly prolongs survival in men with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE